![John L. Mee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
John L.
Mee is the founder of Cognigenics, Inc. and currently holds the title of President.
Cargos activos de John L. Mee
Empresas | Cargo | Inicio |
---|---|---|
Cognigenics, Inc.
![]() Cognigenics, Inc. Miscellaneous Commercial ServicesCommercial Services Cognigenics, Inc. is a company founded in 2019 that specializes in genetic neuroengineering using patent-pending CRISPR technology to target and modulate neural circuits responsible for mental health disorders such as anxiety, depression, ADHD, and cognitive impairment. The company is based in Eagle, ID. Cognigenics is revolutionizing the treatment of mental health conditions through their innovative technology. The company was founded by John L. Mee, Dean Radin, and Barry J. Linder, with John L. Mee serving as CEO since incorporation. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Cognigenics, Inc.
![]() Cognigenics, Inc. Miscellaneous Commercial ServicesCommercial Services Cognigenics, Inc. is a company founded in 2019 that specializes in genetic neuroengineering using patent-pending CRISPR technology to target and modulate neural circuits responsible for mental health disorders such as anxiety, depression, ADHD, and cognitive impairment. The company is based in Eagle, ID. Cognigenics is revolutionizing the treatment of mental health conditions through their innovative technology. The company was founded by John L. Mee, Dean Radin, and Barry J. Linder, with John L. Mee serving as CEO since incorporation. | Commercial Services |
- Bolsa de valores
- Insiders
- John L. Mee